Here we show that a protein kinase, DYRK2, has unexpected role as a scaffold for an E3 ubiquitin ligase complex. DYRK2 associates with an E3 ligase complex containing EDD, DDB1 and VPRBP proteins (EDVP complex). Strikingly, DYRK2 serves as a scaffold for the EDVP complex, because small-interfering-RNA-mediated depletion of DYRK2 disrupts the formation of the EDD-DDB1-VPRBP complex. Although the kinase activity of DYRK2 is dispensable for its ability to mediate EDVP complex formation, it is required for the phosphorylation and subsequent degradation of its downstream substrate, katanin p60. Collectively, our results reveal a new type of E3-ubiquitin ligase complex in humans that depends on a protein kinase for complex formation as well as for the subsequent phosphorylation, ubiquitylation and degradation of their substrates.
DYRK2 is a member of an evolutionarily conserved family of dualspecificity tyrosine-phosphorylation-regulated kinases (DYRKs) that belongs to the CMGC group of protein kinases 1, 2 . During protein synthesis, DYRK2 autophosphorylates a tyrosine residue in its own activation loop. Once autophosphorylated at this tyrosine residue, DYRK2 loses its tyrosine kinase activity and functions only as a serine/threonine kinase 3 . DYRK2 phosphorylates a very limited number of substrates such as NFAT 4 , eIFB 5 , Glycogen synthase 6 , Oma-1 (ref. 7) , MEI-1 (ref. 8 ) and the chromatin remodelling factors SNR1 and TRX 9 , thus regulating calcium signalling, protein synthesis, glucose metabolism, developmental processes and gene expression. Recently, DYRK2 has also been suggested to function in the DNA damage signalling pathway by phosphorylating p53 at serine 46 in the nucleus and promoting cellular apoptosis after genotoxic stress 10 . In addition to its role in cellular responses and developmental processes, DYRK2 is a potential oncogene 11 , because DYRK2 amplification and overexpression have been reported in adenocarcinomas of the oesophagus and lung 12 . However, the exact mechanism of DYRK2 in tumorigenesis remains to be clarified.
RESultS

DYRK2 associates with EDVP E3 ligase complex
In an attempt to elucidate DYRK2 function further, we established 293T derivative cell line stably expressing a triple-epitope (S-protein, Flag and streptavidin-binding peptide)-tagged version of DYRK2 (SFB-DYRK2). Tandem affinity purification with streptavadin-agarose beads and S-protein-agarose beads followed by mass spectrometry analysis allowed us to discover several proteins that interacted with DYRK2 ( Fig. 1a and Supplementary Information, Table S1 ). Among them we repeatedly identified EDD, DDB1 and VPRBP as major DYRK2-associated proteins (Fig. 1a) . EDD (also known as UBR5, hHYD or KIAA0896) is an E3 ligase with a distinct amino-terminal UBA domain, a UBR box and a carboxy-terminal HECT domain that mediates ubiquitin-dependent protein degradation 13, 14 . EDD is likely to be involved in tumorigenesis, because an allelic imbalance at the EDD locus has been reported in several cancers 15, 16 . DDB1 (DNA-damage binding protein 1) 17 is an adaptor subunit of the Cul4-Roc1 E3 ligase complex 18 that mediates the ubiquitin-dependent degradation of various substrates including Cdt1, p21
Cip1/WAF1 and c-Jun. VPRBP (also known as DCAF1) 19, 20 , a WD40-domain-containing protein, is a substrate recognition subunit of the DDB1-Cul4A-Roc1 complex.
By transient overexpression of SFB-DYRK2 in 293T cells, we confirmed the interaction of DYRK2 in vivo with EDD, DDB1 and VPRBP (Fig. 1b) . Although DDB1 and VPRBP have been discovered recently as key components in the Cul4-Roc1 E3 ligase complex 18, 21, 22 , surprisingly we did not identify either Cul4 or Roc1 in our purification. Indeed, we could not detect any interaction of overexpressed DYRK2 with either Cul4A or Roc1 (Fig. 1b) , confirming that Cul4 and Roc1 are not components of this novel complex, which contains DYRK2, EDD, DDB1 and VPRBP. We further confirmed the existence of this complex in vivo by demonstrating that endogenous DYRK2 co-immunoprecipitated with EDD, DDB1 and VPRBP (Fig. 1c) . In contrast, Cul4A-Roc1 components were not seen in EDD immunoprecipitates (Fig. 1c) . However, neither EDD nor DYRK2 was seen in Cul4A immunoprecipitates, supporting the notion that the presence of the EDVP complex is independent of the Cul4A-Roc1 complex (Fig. 1c) . The interactions between EDD, DDB1 and VPRBP with DYRK2 are specific, because we could only observe these associations in cells transfected with control small interfering RNA (siRNA) but not in cells after transfection with DYRK2-specific siRNA ( Supplementary Information, Fig. S1a ). In addition, exogenously expressed Myc-EDD interacted only with Flag-DYRK2 but not with another DYRK family member, DYRK1B ( Supplementary Information,  Fig. S1b, c) , underlining the specificity of the interaction between DYRK2 Anti-Cul4A table at the right and also in Supplementary Information, Table S1 . and EDD. Bacterially expressed glutathione S-transferase (GST)-tagged DYRK2 pulled down EDD, DDB1 and VPRBP, but not Cul4A from cell extracts (Fig. 1d) , again arguing that DYRK2 forms a distinct complex with EDD, DDB1 and VPRBP. The formation of a DYRK2-EDD-DDB1-VPRBP complex might not be strictly regulated by the cell cycle, because we observed an interaction of DYRK2 with the other components of the complex independently of cell cycle phases, although the levels of EDD and VPRBP interacting with DYRK2 vary and are proportional to their protein levels at specific phases of the cell cycle ( Supplementary  Information, Fig. S2c ). EDD is a known HECT-domain-containing E3 ligase that regulates the ubiquitin-dependent degradation of its substrates 14 . We named this E3 ligase complex containing EDD, DDB1 and VPRBP proteins the EDVP complex, to distinguish it from the previously identified Cul4-Roc1-DDB1-VPRBP E3 ligase complex. To assess the significance of the interaction between DYRK2 and this new EDVP E3 ligase complex, we checked DYRK2 protein levels in cells depleted of EDD, DDB1 or VPRBP. We found no difference between the DYRK2 protein levels in any of the knockdown cells in comparison with control-siRNA-transfected cells ( Supplementary Information, Fig. S2a ). We also checked the protein levels of DYRK2, EDD and VPRBP at different phases of the cell cycle. Whereas the levels of EDD and VPRBP fluctuated during the cell cycle, DYRK2 levels remained constant ( Supplementary Information,  Fig. S2b ), thus ruling out the possibility that DYRK2 may be a target for proteasomal degradation mediated by the EDVP ligase complex.
DYRK2 acts as an adaptor in the EDVP complex
Several Kelch-motif-containing proteins were shown previously to act as E3 ligase adaptors for specific substrates [23] [24] [25] . A preliminary analysis of the DYRK2 protein sequence revealed the presence of a Kelch motif (amino-acid residues 390-433) within its protein kinase catalytic domain ( Supplementary Information, Fig. S3 ), so we next investigated whether DYRK2 functions as a molecular adaptor in the EDVP ligase complex. We depleted DYRK2 with siRNA and checked for complex formation of EDD, DDB1 and VPRBP. The interaction of EDD with DDB1 and VPRBP was seen only in the presence of intact DYRK2, whereas the knockdown of DYRK2 led to a loss of the interaction between EDD and DDB1 or VPRBP (Fig. 2a) . Neither the interaction of DDB1 with VPRBP nor the association of Cul4A with DDB1-VPRBP was affected by the absence of DYRK2 (Fig. 2a) . These experiments suggest that DYRK2 functions as a scaffold, required for the specific recruitment of EDD to DDB1-VPRBP, thus forming a novel EDVP E3 ligase complex. Surprisingly, DYRK2 kinase activity is dispensable as an scaffold for this E3 ligase complex, since the transfection of either siRNA-resistant wildtype DYRK2 or kinase-inactive DYRK2 (each of which was validated by both expression and kinase activity with a synthetic peptide; Fig. 2b ), into DYRK2-depleted cells was able to restore the association of EDD with the DDB1-VPRBP complex (Fig. 2c ).
EDVP-DYRK2 complex regulates katanin p60 ubiquitylation
We next examined the likely substrates of this new E3 ligase complex. Previously, MBK-2, the Caenorhabditis elegans homologue of mammalian DYRK2, was shown to phosphorylate and regulate MEI-1 during meiotic maturation in C. elegans 8 . MEI-1 (a C. elegans homologue of katanin p60) is an AAA-ATPase that associates with MEI-2 and functions as a microtubule-severing enzyme. When the C. elegans embryo enters the first mitotic division after exiting from the meiosis, MBK2 phosphorylates MEI-1, which is then degraded through a ubiquitin-dependent mechanism by binding to MEL-26, a BTB-domaincontaining substrate adaptor protein complexed with Cul3 (ref. 24) . The ubiquitin-mediated degradation of MEI-1/katanin was further regulated by a series of neddylation and deneddylation of Cul3 mediated by COP9/signalosome 26 . In higher eukaryotes, it is not yet known whether DYRK2 regulates katanin p60. We therefore first tested and showed that katanin p60 readily associated with the DYRK2-EDVP complex in vivo (Fig. 3a) . To identify the direct katanin-binding subunit of the EDD-DDB1-VPRBP complex, we performed an in vitro binding assay using bacterially expressed recombinant maltose-binding protein (MBP)-tagged EDD, DDB1 and VPRBP along with GST-tagged katanin. Recombinant katanin directly binds VPRBP but not EDD and DDB1 in vitro (Fig. 3b) . In addition, katanin interacts with EDD and DDB1 only in the presence of intact VPRBP but not in VPRBP knockdown cells, thus confirming VPRBP as the substrate-binding receptor subunit in the EDVP complex (Fig. 3c) . We further examined whether the associated katanin p60 is a substrate of the DYRK2-EDVP E3 ligase complex. We evaluated endogenous katanin ubiquitylation in cells transfected with either control siRNA or siRNAs specific for different components of the DYRK2-EDVP complex in the presence of MG132, a proteasomal inhibitor. Katanin p60 was polyubiquitylated in the presence of the intact DYRK2-EDVP, but its ubiquitylation was severely decreased by the depletion of DYRK2, EDD, DDB1 or VPRBP (Fig. 3d) . In contrast, katanin polyubiquitylation was unaffected in cells transfected with siRNAs against Cul4A and Cul4B. Previously, it was shown that Cul3/ MEL26 also has a function in the degradation of MEI-1 (a C. elegans homologue of katanin p60) during meiotic maturation of C. elegans 24, 26 . We therefore tested whether a similar mechanism for katanin regulation occurs in humans. Interestingly, knocking down Cul3 does lead to a modest decrease in katanin polyubiquitylation, although the severity of this decrease is not comparable with those observed in cells with knockdown of subunits of the EDVP complex (Fig. 3d) . It is therefore likely that the EDVP complex has a primary function, whereas Cul3 is of secondary importance in promoting katanin polyubiquitylation in
Anti-Cul3 human cells. We also investigated whether EDD is the functional E3 ligase in the EDVP complex. Knockdown of EDD with siRNA severely affected katanin polyubiquitylation. This defect in katanin ubiquitylation was fully rescued by the expression of siRNA-resistant wild-type EDD, but not by the expression of a catalytically inactive HECT-domain mutant of EDD (Fig. 3e) . EDD is therefore the catalytic subunit in this E3 ligase complex. Polyubiquitylation of katanin by the DYRK2-EDVP complex is likely to be required for katanin degradation, as knockdown of DYRK2, EDD, DDB1 or VPRBP, but not that of Cul4A and Cul4B, increased the steady-state levels of katanin protein (Fig. 4a) . Knockdown of Cul3 also resulted in a small increase in katanin protein levels, again suggesting a secondary role of the Cul3 complex in katanin degradation. In addition, in a cycloheximide chase experiment, Myc-tagged katanin was stabilized in cells depleted of DYRK2, EDD or VPRBP in comparison with cells transfected with control siRNAs. In sharp contrast, overexpression of DYRK2, DDB1 or VPRBP along with katanin led to diminished katanin stability (Fig. 4b) . Taken together, these data suggest that katanin is a substrate of the DYRK2-EDVP E3 ligase complex. Because anaphase-promoting complex (APC) was also shown to work with MBK-2 and regulate the degradation of C. elegans katanin p60 in a Cul3 redundant pathway 8 , we knocked down APC2, a critical subunit of APC, in human cells. However, we did not observe any change in katanin protein levels (Fig. 4c) and therefore concluded that APC may not be involved in katanin degradation in humans.
DYRK2-mediated phosphorylation is required for katanin p60 degradation MBK2/DYRK2 is known to phosphorylate the katanin homologue MEI-1 in C. elegans 27 . We next investigated whether DYRK2 would phosphorylate katanin and be required for katanin ubiquitylation by the EDVP complex. In vitro kinase assays revealed that immunoprecipitated wildtype DYRK2, but not kinase-inactive DYRK2, could phosphorylate bacterially expressed GST-katanin (Fig. 5a) . We also tested whether DYRK2 in the EDVP complex could phosphorylate katanin by performing immunoprecipitation of the EDVP complex followed by an in vitro kinase assay. Immunoprecipitates of EDD, DDB1 and VPRBP, but not of Cul4A, showed intrinsic kinase activity towards katanin (Fig. 5b) , suggesting that DYRK2 in the EDVP complex is still capable of phosphorylating its substrate. Katanin contains several consensus DYRK2 phosphorylation sites 28 (Fig. 5c ). We mutated katanin at these serine or threonine residues individually or in combination and examined whether any of these residues were potential DYRK2 phosphorylation sites in vitro. Serine 42, serine 109 and threonine 133 are likely to be the major DYRK2 phosphorylation sites, because single mutations at these sites showed decreased phosphorylation by DYRK2, and the triple mutant showed almost no DYRK2-mediated phosphorylation (Fig. 5d) . Furthermore, we detected the presence of phosphoserine and phosphothreonine residues in the immunoprecipitated wild-type katanin (Fig. 5e) , indicating that katanin is phosphorylated in vivo. However, these phosphorylations were greatly diminished in the triple phospho-mutant (AAA mutant) of katanin ( Fig. 5f ), suggesting that these residues are indeed major phosphorylation sites in vivo.
We further investigated whether the DYRK2-mediated phosphorylation of katanin is required for its ubiquitylation in vivo. Ubiquitylation of Myc-tagged wild-type katanin was easily detected, whereas the ubiquitylation of the AAA mutant of katanin was severely diminished (Fig. 6a) . To further support the idea that the intact DYRK2-EDVP complex mediates the ubiquitylation of phosphorylated katanin, we performed in vitro reconstitution assays with GST-katanin as the ubiquitylation substrate. As shown in Fig. 6b , only the intact EDVP complex containing wild-type EDD (but not mutant EDD) resulted in robust Supplementary Information, Fig. S4. katanin polyubiquitylation. Previous phosphorylation of katanin is essential for katanin ubiquitylation: only wild-type katanin, but not its AAA mutant, could be readily ubiquitylated by the EDVP complex in vitro (Fig. 6c) . These data suggest that DYRK2-dependent katanin phosphorylation is a prerequisite for katanin ubiquitylation, indicating that DYRK2 kinase activity is critical for the function of the DYRK2-EDVP E3 ligase complex. The phosphorylation-dependent degradation of katanin was substantiated by co-transfection experiments. Co-transfection of wild-type DYRK2, but not kinase-inactive DYRK2, along with katanin decreased the steady-state levels of katanin protein (Fig. 6d) . In contrast, Supplementary Information, Fig. S4 . the protein levels of the AAA katanin mutant remained largely unaffected (Fig. 6d) , suggesting that DYRK2-mediated phosphorylation is a priming event required for katanin ubiquitylation and degradation.
EDVP-DYRK2 complex controls mitotic transition
Previous studies have reported that katanin is a microtubule AAAATPase that is important in mitosis 29, 30 . Katanin is required for severing microtubules at the mitotic spindles when disassembly of the microtubules is required for the segregation of sister chromatids during anaphase. Both DYRK2 (ref. 7) and EDD 31 have also been suggested to function during mitosis. To establish a functional link between the DYRK2-EDVP ligase complex and katanin degradation, we checked the cell cycle profile of HeLa cells transiently transfected with katanin. Overexpression of katanin led to the accumulation of a 4N population and polyploid (>4N) cells (Fig. 7a) . Similarly, siRNA-mediated downregulation of either DYRK2 or EDD, which led to an upregulation of katanin (Fig. 7b) , also resulted in the accumulation of cells with a 4N DNA content (Fig. 7a) . This abnormal accumulation of 4N cells after depletion of DRYK2 or EDD could be rescued by the simultaneous depletion of katanin by siRNA (Fig. 7a) . In addition, DYRK2-mediated katanin phosphorylation is required for proper cell cycle progression: co-expression of DYRK2 with the katanin AAA mutant but not wild-type katanin led to an increase in cells with a 4N DNA content (Fig. 7c) . This increase in the 4N population is attributed to defective mitotic progression, because we observed an increased number of phospho-H3-positive cells when wild-type or non-phosphorylatable katanin was overexpressed (Fig. 7d) . Co-expression of wild-type DYRK2 but not the kinase-dead version with wild-type katanin decreased the number of mitotic cells to normal levels, whereas co-expression of DYRK2 with the katanin AAA mutant failed to rescue this mitotic defect (Fig. 7d) . Collectively, these results suggest that an active DYRK2-EDVP ligase complex regulates mitotic transition through the modulation of katanin protein levels.
DiSCuSSioN
Protein kinases regulate a variety of biological processes, including cell proliferation, apoptosis, development and tumorigenesis by phosphorylating their respective downstream substrates 32 . In this study we have uncovered a novel role for protein kinase; for example, it functions as an assembly factor for an E3 ubiquitin ligase complex. In particular, we have shown that DYRK2 has dual roles in this E3 ligase complex. Not only is it required for the assembly of the complex, but it also phosphorylates its substrate and primes the substrate for degradation. Phosphorylationdependent protein degradation is a common mechanism for regulating protein stability in a cell-cycle-dependent or stimulus-dependent manner. This often occurs as a two-step process 33 , in which initially a kinase phosphorylates the substrate. Once phosphorylated, the substrate is recognized by F-box-containing or BC-box substrate receptor proteins and targeted to E3 ligase complexes for degradation. Here we provide evidence for the integral presence of a kinase, DYRK2, within the EDD-DDB1-VPRBP (EDVP) E3 ligase complex, which merges the functional properties of a protein kinase and an E3 ligase into a single unit that can recognize, phosphorylate and degrade substrates in concert. It is currently unclear how DYRK2-mediated phosphorylation of katanin promotes its ubiquitylation, but it is possible that phosphorylation of katanin leads to a conformational change that exposes some of the substrate residues for efficient ubiquitylation by EDD. Our functional studies further suggest that the DYRK2-EDVP E3 ligase complex has a crucial function in regulating normal mitotic progression. Because overexpression of both DYRK2 (refs 11, 12) and EDD 15, 16 is frequently reported in cancers, it is tempting to speculate that aberrant mitosis and altered cell cycle progression through the hyperactivation of the DYRK2-EDVP E3 ligase complex might be a key mechanism in promoting neoplastic transformation. Future studies with animal models will reveal the role of this DYRK2-EDVP complex in cancer development and progression.
MEtHoDS
Plasmids. Full-length DYRK2, DYRK1B, EDD, DDB1, VPRBP, Cul4A, katanin and DYRK2-KD were cloned into a S-protein-Flag-SBP (streptavidin-binding protein) triple tagged destination vector with the Gateway cloning system (Invitrogen). Full-length EDD, katanin and katanin AAA mutant were also cloned to a Myc-tagged destination vector. GST-tagged DYRK2, MBP-tagged EDD, catalytically inactive EDD (EDD C/A), DDB1 and VPRBP bacterial expression vectors were generated by transferring their coding sequences into destination vectors with the Gateway system. Various deletion and point mutants for katanin p60 and the kinase-dead version of DYRK2 were generated by PCR-based site-directed mutagenesis. Wild-type katanin and mutants of katanin were also cloned to a GST-tagged vector. Constructs of Myc-tagged ubiquitin and haemagglutinin (HA)-tagged ubiquitin were used in ubiquitylation assays in vivo. siRNA-resistant wild-type DYRK2, kinase-dead DYRK2, wild-type EDD and EDD C/A mutant constructs were generated by introducing silent mutations into their respective triple-tagged vectors by using site-directed mutagenesis; the constructs were verified by sequencing.
Antibodies. Rabbit anti-katanin antibodies were raised by immunizing rabbits with GST-katanin p60 fusion protein (residues 30-240). Antisera were affinitypurified with the AminoLink Plus Immobilization and Purification Kit (Pierce). Anti-DYRK2 (Abcam), anti-EDD, anti-DDB1, anti-VPRBP, anti-Cul4A, anti-Cul3 (all from Bethyl Laboratories), anti-FBX22 (Novus Biologicals), anti-PBK (Cell Signaling Technology), anti-Flag, anti-(maltose-binding protein); Clone 17, antiactin, anti-Cul4B (Sigma), anti-Roc1 (Invitrogen), anti-GST, anti-Myc; Clone 9E10 (Santa Cruz Biotechnologies), anti-phosphoserine H3, anti-phosphothreonine (Cell Signaling Technology) and anti-phosphoserine, anti-ubiquitin (Millipore) antibodies were used in this study.
Tandem affinity purification. 293T cells were transfected with S-protein-Flag-SBP triple-tagged DYRK2; three weeks later, puromycin-resistant colonies were selected and screened for DYRK2 expression. The DYRK2-positive stable cells were then maintained in RPMI medium supplemented with fetal bovine serum and 2 µg ml −1 puromycin. The SFB-DYRK2 stable cells were lysed with NETN buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 1 mM EDTA, 0.5% Nonidet P40) containing 50 mM β-glycerophosphate, 10 mM NaF, 1 µg ml −1 pepstatin A and 1 µg ml −1 aprotinin on ice for 20 min. After removal of cell debris by centrifugation, crude cell lysates were incubated with streptavidin-Sepharose beads (Amersham Biosciences) for 1 h at 4 °C. The bound proteins were washed three times with NETN buffer and then eluted twice with 2 mg ml −1 biotin (Sigma) for 30 min at 4 °C. The eluates were incubated with S-protein-agarose beads (Novagen) for 1 h at 4 °C and then washed three times with NETN buffer. The proteins bound to S-protein-agarose beads were resolved by SDS-PAGE and revealed by staining with Coomassie blue. The identities of eluted proteins were revealed by mass spectrometry analysis performed at the Taplin Biological Mass Spectrometry Facility, Harvard University.
Cell transfections, immunoprecipitation and immunoblotting. 293T cells or HeLa cells were transfected with various plasmids by using Lipofectamine (Invitrogen) in accordance with the manufacturer's protocol. For immunoprecipitation assays, cells were lysed with NETN buffer as described above. The whole-cell lysates obtained by centrifugation were incubated with 2 µg of specified antibody bound to either protein A-Sepharose or protein G-Sepharose beads (Amersham Biosciences) for 1 h at 4 °C. The immunocomplexes were then washed with NETN buffer four times and subjected to SDS-PAGE. Immunoblotting was performed with standard protocols.
In vitro kinase assay. Wild-type DYRK2 and kinase-inactive DYRK2, which were expressed in 293T cells, were immunoprecipitated with Flag-agarose beads and used as a kinase source. GST-tagged katanin and its mutant proteins, expressed in Escherichia coli strain BL21, were purified with glutathione-Sepharose beads and used as substrates. The kinase (DYRK2) and substrates (katanin) were incubated in kinase assay buffer (10 mM HEPES pH 7.5, 50 mM NaCl, 10 nM MgCl 2 , 10 mM MnCl 2 , 1 mM EGTA, 1 mM dithiothreitol, 5 µM ATP, 10 mM NaF, 50 mM glycerophosphate) along with 10 µCi of [γ-32 P] ATP) for 30 min at 30 °C. Reactions were stopped by the addition of SDS sample buffer. Then samples were boiled for 5 min at 100 °C followed by SDS-PAGE and autoradiography. The validation of siRNA-resistant wild-type DYRK2 and kinase-dead DYRK2 was performed by DYRK2 immunoprecipitation followed by a kinase assay with a synthetic Woodtide peptide (KKISGRLSPIMTEQ) as a substrate (purchased from Millipore).
In vivo ubiquitylation assay. HeLa cells were transfected with various combinations of plasmids as indicated in Figs 2d and 3f along with either Myc-tagged ubiquitin or HA-tagged ubiquitin. At 24 h after transfection, cells were treated with MG132 (4 µΜ) for 6 h and the whole-cell extracts prepared by lysis in NETN buffer were subjected to immunoprecipitation of the substrate protein. Analysis of ubiquitylation was performed by immunoblotting with either anti-Myc or anti-HA antibodies.
In vitro reconstitution assay. The reactions were performed at 30 °C for 15 min in 25 µl of ubiquitylation reaction buffer (40 mM Tris-HCl pH 7.6, 2 mM dithiothreitol, 5 mM MgCl 2 , 0.1 M NaCl, 2 mM ATP) containing the following components: 100 µΜ ubiquitin, 20 nM E1 (UBE1) and 100 nM UbcH5b (all from Boston Biochem). Various combinations of EDVP E3 ligase components (25 ng of EDD or EDD C/A, plus DDB1, VPRBP and DYRK2) as indicated were added to the reaction. Either wild-type GST-katanin or the AAA mutant bound to glutathioneSepharose beads was used as a substrate in the reaction. After ubiquitylation reaction, the glutathione-Sepharose beads were washed five times with NETN buffer and boiled with SDS-PAGE loading buffer; the ubiquitylation of katanin was monitored by western blotting with anti-ubiquitin antibody.
Cell cycle analysis. HeLa cells transfected with the desired expression vectors and siRNA were harvested, washed with phosphate-buffered saline and fixed with ice-cold 70% ethanol for at least 1 h. Cells were washed twice in PBS and treated for 30 min at 37 °C with RNase A (5 µg ml −1 ) and propidium iodide (50 µg ml −1 ), then analysed on a FACScan flow cytometer (Becton Dickinson). The percentage of cells in different cell cycle phases was calculated with Flowjo analysis software.
Immunofluorescence staining. Cells grown on coverslips were fixed with 3% paraformaldehyde solution in PBS containing 50 mM sucrose at 25 °C for 15 min. After permeabilization at room temperature with 0.5% Triton X-100 buffer containing 20 mM HEPES pH 7.4, 50 mM NaCl, 3 mM MgCl 2 and 300 mM sucrose for 5 min, cells were incubated with a primary phosphoserine H3 antibody at 37 °C for 20 min. After being washed with PBS, cells were incubated with rhodamine-conjugated secondary antibody at 37 °C for 20 min. Nuclei were counterstained with DAPI (4,6-diamidino-2-phenylindole). After a final wash with PBS, coverslips were mounted in glycerine containing p-phenylenediamine. 
